Incidence of bony secondary at presentation of breast carcinoma in our region.

dc.contributor.authorIslam, S Men_US
dc.contributor.authorMahmood, Sen_US
dc.contributor.authorHossain, G Aen_US
dc.contributor.authorKhan, Nen_US
dc.contributor.authorChakraborty, R Ken_US
dc.contributor.authorUddin, Ken_US
dc.contributor.authorIslam, Aen_US
dc.contributor.authorRahman, Men_US
dc.date.accessioned2003-01-29en_US
dc.date.accessioned2009-05-27T03:53:08Z
dc.date.available2003-01-29en_US
dc.date.available2009-05-27T03:53:08Z
dc.date.issued2003-01-29en_US
dc.descriptionMymensingh Medical Journal.en_US
dc.description.abstractStudy is conducted to evaluate the incidence of bony secondary and to evaluate the need for routine bone scintigraphy at the time of presentation of breast carcinoma in this region. Of the total 130 patients evaluated by bone scan, sixty (n = 60, 46.15%) had secondary lesion in bone. Among the 54 preoperative patients, all with positive FNAC, twenty (n = 20, 37.03%) had bony metastases. Of the 76 post-operative patients, forty (n = 40, 52.63%) had secondary bone lesions. Single lesion was seen in only five (n = 5, 8.53%) cases. Rest fifty five (n = 55, 91.67%) had multiple bony secondaries. Most of the postoperative cases (n = 40, 52.63%) were invasive/infiltrative duct cell carcinoma. The very high incidence of bony secondary appears to be due to delayed presentation associated with poor socioeconomic condition, ignorance and also shyness. Bony metastases at the time of presentation suggests poor prognosis. As it can affect therapeutic management of these patients, routine bone scintigraphy at the time of presentation of breast carcinoma patients to a tertiary label hospital is proposed, against conflicting conclusion by papers in the developed countries.en_US
dc.description.affiliationNuclear Medicine Centre, Mymensingh. drmoinul@bttb.net.bden_US
dc.identifier.citationIslam SM, Mahmood S, Hossain GA, Khan N, Chakraborty RK, Uddin K, Islam A, Rahman M. Incidence of bony secondary at presentation of breast carcinoma in our region. Mymensingh Medical Journal. 2003 Jan; 12(1): 25-9en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/1289
dc.language.isoengen_US
dc.subject.meshAdulten_US
dc.subject.meshAge Distributionen_US
dc.subject.meshAgeden_US
dc.subject.meshBangladesh --epidemiologyen_US
dc.subject.meshBone Neoplasms --epidemiologyen_US
dc.subject.meshBreast Neoplasms --pathologyen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshIncidenceen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshPostoperative Care --statistics & numerical dataen_US
dc.subject.meshPreoperative Care --statistics & numerical dataen_US
dc.titleIncidence of bony secondary at presentation of breast carcinoma in our region.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: